Health product recall

0.4% Lidocaine Hydrochloride & 5% Dextrose Injection: Solution bags may be leaking in affected lots. (Updated with new lot numbers)

Last updated

Summary

Product
0.4% Lidocaine Hydrochloride & 5% Dextrose Injection
Issue
Health products - Packaging
What to do

Consult your health care professional if you have any health concerns.

Distribution
Alberta
British Columbia
Manitoba
New Brunswick
Newfoundland and Labrador
Northwest Territories
Nova Scotia
Ontario
Prince Edward Island
Quebec
Saskatchewan
Yukon

Affected products

Brand Product Name Market Authorization Dosage Form Strength Lot
Baxter 0.4% Lidocaine Hydrochloride & 5% Dextrose Injection DIN 00828602 Solution DEXTROSE 50 MG / ML LIDOCAINE HYDROCHLORIDE 4 MG / ML W3B01C1X Updated lot number: W3E11C1

Issue

Solution bags may be leaking in affected lots.

What you should do

  1. Verify if your product is affected.
  2. Contact the recalling firm if you have any questions about the recall.
  3. Report any health product related side effects to Health Canada.
  4. Report any other health product safety complaints to Health Canada.

Additional information

Previous recalls or alerts
Background

Depth of recall: Wholesalers, Retailers, Healthcare establishments

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

BAXTER CORPORATION

7125 Mississauga Road, Mississauga

Ontario Canada L5N 0C2

Published by
Health Canada
Audience
General public
Healthcare
Industry
Distribution
Alberta
British Columbia
Manitoba
New Brunswick
Newfoundland and Labrador
Northwest Territories
Nova Scotia
Ontario
Prince Edward Island
Quebec
Saskatchewan
Yukon
Recall class
Type I
Identification number
RA-73983